Stay updated on Pembrolizumab Combo in Neuroendocrine Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Neuroendocrine Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Neuroendocrine Carcinoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.3.2, replacing Revision: v3.3.1. This appears to be a site revision update and does not alter the study details.
    Difference
    0.1%
    Check dated 2025-12-01T17:29:56.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.1, representing a minor template/version update with no changes to core study information or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T14:42:22.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Removed a site-wide notice about potential delays and updates due to a lapse in government funding; the trial content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T06:54:17.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    Only minor visual/UI adjustments and timestamp updates were observed; the core study details remain unchanged (To avoid being alerted by small changes, set an alert condition by clicking below).
    Difference
    0.5%
    Check dated 2025-11-03T01:19:35.000Z thumbnail image
  5. Check
    64 days ago
    Change Detected
    Summary
    Overall, the page updates to announce a system status notice and a new software version (v3.2.0), removing the previous v3.1.0 reference.
    Difference
    3%
    Check dated 2025-10-05T10:17:36.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0. The core page content shifts to the newer release identifier; no other substantive content changes are indicated.
    Difference
    0.1%
    Check dated 2025-09-28T03:17:41.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Neuroendocrine Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Neuroendocrine Carcinoma Clinical Trial page.